Food allergy is a common health problem worldwide, with increasing prevalence during recent decades. The only approved treatments for food allergy are food avoidance and administration of emergency medications in case of accidental exposure, which negatively affects patients' quality of life, so new treatments are highly desirable. Different food immunotherapy modalities have recently been used, with variable success rates in the induction of desensitization and tolerance, and different numbers and types of adverse reactions. Adverse reactions, especially intolerable gastrointestinal symptoms, are the most important causes of immunotherapy withdrawal. Eosinophilic esophagitis has been reported as a complication of milk, egg, and peanut oral immunotherapies and sublingual immunotherapy for respiratory allergies, but not for food allergies. Eosinophilic gastritis and eosinophilic colitis also rarely happened following egg and milk oral immunotherapies. The patients undergoing oral and sublingual immunotherapies should be closely followed up for a long time, and those with gastrointestinal symptoms should be evaluated by endoscopy of the gastrointestinal tract. These complications are usually reversible after early diagnosis and stopping the immunotherapy protocol.

1.
Nowak-Wegrzyn A, Burks AW, Sampson HA: Reactions to foods; in Adkinson FA, Bochner BS, Burks AW, Busse WW, Holgate ST, Lemanske RF, O'Hehir RE (eds): Middleton's Allergy Principles and Practice. Philadelphia, Elsevier Saunders, 2014, vol 2, pp 1310-1339.
2.
Branum AM, Lukacs SL: Food allergy among children in the United States. Pediatrics 2009;124:1549-1555.
3.
Sicherer SH, Sampson HA: Food allergy: recent advances in pathophysiology and treatment. Annu Rev Med 2009;60:261-277.
4.
Wood RA: Food allergen immunotherapy: current status and prospects for the future. J Allergy Clin Immunol 2016;137:973-982.
5.
McGowan EC, Wood RA: Sublingual (SLIT) versus oral immunotherapy (OIT) for food allergy. Curr Allergy Asthma Rep 2014;14:486.
6.
Dogruel D, Bingöl G, Altıntaş DU, Yılmaz M, Güneşer Kendirli S: Clinical features of food allergy during the 1st year of life: the ADAPAR Birth Cohort Study. Int Arch Allergy Immunol 2016;169:171-180.
7.
Valenta R, Hochwallner H, Linhart B, Pahr S: Food allergies: the basics. Gastroenterology 2015;148:1120-1131.
8.
McBride D, Keil T, Grabenhenrich L, Dubakiene R, Drasutiene G, Fiocchi A, Dahdah L, Sprikkelman AB, Schoemaker AA, Roberts G, Grimshaw K, Kowalski ML, Stanczyk-Przyluska A, Sigurdardottir S, Clausen M, Papadopoulos NG, Mitsias D, Rosenfeld L, Reche M, Pascual C, Reich A, Hourihane J, Wahn U, Mills EN, Mackie A, Beyer K: The EuroPrevall birth cohort study on food allergy: baseline characteristics of 12,000 newborns and their families from nine European countries. Pediatr Allergy Immunol 2016;23:230-239.
9.
Sampson HA: Food allergy: a practice parameter update - 2014. J Allergy Clin Immunol 2014;134:1016-1069.
10.
Boyce J, Assa'ad AH, Burks AW, et al: Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID sponsored expert panel report. J Allergy Clin Immunol 2010;126(suppl):S1-S58.
11.
Sicherer SH, Munoz-Furlong A, Godbold JH, Sampson HA: US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010;125:1322-1326.
12.
Dey D, Ghosh N, Pandey N, Gupta Bhattacharya S: A hospital-based survey on food allergy in the population of Kolkata, India. Int Arch Allergy Immunol 2014;164:218-221.
13.
Burks AW, Tang M, Sicherer S, Muraro A, Eigenmann PA, Ebisawa M, et al: ICON: food allergy. J Allergy Clin Immunol 2012;129:906-920.
14.
Doğruel D, Bingöl G, Yılmaz M, Altıntaş DU: The ADAPAR Birth Cohort Study: food allergy results at five years and new insights. Int Arch Allergy Immunol 2016;169:57-61.
15.
Savage JH, Matsui EC, Skripak JM, Wood RA: The natural history of egg allergy. J Allergy Clin Immunol 2007;120:1413-1417.
16.
Savage JH, Kaeding AJ, Matsui EC, Wood RA: The natural history of soy allergy. J Allergy Clin Immunol 2010;125:683-686.
17.
Martinet J, Couderc L, Renosi F, Bobée V, Marguet C, Boyer O: Diagnostic value of antigen-specific immunoglobulin E immunoassays against Ara h 2 and Ara h 8 peanut components in child food allergy. Int Arch Allergy Immunol 2016;169:216-222.
18.
Sicherer SH, Munoz-Furlong A, Sampson HA: Prevalence of seafood allergy in the United States determined by a random telephone survey. J Allergy Clin Immunol 2004;114:159-165.
19.
Sicherer SH, Sampson HA: Food allergy. J Allergy Clin Immunol 2010;125(suppl 2):S116-S125.
20.
Sicherer SH, Noone SA, Muñoz-Furlong A: The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 2001;87:461-464.
21.
Skripak JM, Matsui EC, Mudd K, Wood RA: The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2007;120:1172-1177.
22.
Bublin M, Breiteneder H: Developing therapies for peanut allergy. Int Arch Allergy Immunol 2014;165:179-194.
23.
Nelson HS: Injection immunotherapy for inhalant allergens; in Adkinson FA, Bochner BS, Burks AW, Busse WW, Holgate ST, Lemanske RF, O'Hehir RE (eds): Middleton's Allergy Principles and Practice. Philadelphia, Elsevier Saunders, 2014, vol 2, pp 1416-1437.
24.
Pfützner W: Allergen-specific tolerance induction: of mice and men. Int Arch Allergy Immunol 2015;166:81-83.
25.
Sato S, Yanagida N, Ogura K, Imai T, Utsunomiya T, Iikura K, Goto M, Asaumi T, Okada Y, Koike Y, Syukuya A, Ebisawa M: Clinical studies in oral allergen-specific immunotherapy: differences among allergens. Int Arch Allergy Immunol 2014;164:1-9.
26.
Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY: Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992;90:256-262.
27.
Enrique E, Pineda F, Malek T, Bartra J, Basagana M, Tella R, et al: Sublingual immunotherapy for hazelnut food allergy: a randomized, double blind, placebo controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005;116:1073-1079.
28.
Patriarca G, Nucera E, Pollastrini E, De Pasquale T, Lombardo C, Buonomo A, et al: Oral rush desensitization in peanut allergy: a case report. Dig Dis Sci 2006;51:471-473.
29.
Mansfield L: Successful oral desensitization for systemic peanut allergy. Ann Allergy Asthma Immunol 2006;97:266-267.
30.
Narisety SD, Frischmeyer-Guerrerio PA, Keet CA, Gorelik M, Schroeder J, Hamilton RG, Wood RA: A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol 2015;135:1275-1282 e1-e6.
31.
Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, Hiegel A, Kamilaris J, Carlisle S, Yue X, Kulis M, Pons L, Vickery B, Burks AW: A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011;127:654-660.
32.
Vickery BS, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW: Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 2014;133:468-475.
33.
Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TT, Kulis M, Shreffler WG, Steele P, Henry KA, Adair M, Francis JM, Durham S, Vickery BP, Zhong X, Burks AW: Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009;124:292-300. e1-e97.
34.
Blumchen K, Ulbricht H, Staden U, Dobberstein K, Beschorner J, de Oliveira LC, et al: Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010;126:83-91. e1.
35.
Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, et al: Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012;367:233-243.
36.
Buchanan AD, Green TD, Jones SM, Scurlock AM, Christie LA, lthage KA, Steele PH, Pons L, Helm RM, Lee LA, Burks AW: Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007;119:199-205.
37.
Vickery BP, Pons L, Kulis M, Steele P, Jones SM, Burks AW: Individualized IgE based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol 2010;105:444-450.
38.
Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, Schroeder JT, Hamilton RG, Boden S, Steele P, Driggers S, Burks AW, Wood RA: The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012;129:448-455. e1-e5.
39.
Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG: A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 2004;59:980-987.
40.
Longo G, Barbi E, Berti I, Meneghetti R, Pittalis A, Ronfani L, Ventura A: Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008;121:343-347.
41.
Skripak JM, Nash SD, Rowley H, Brereton NH, Oh S, Hamilton RG, Matsui EC, Burks AW, Wood RA: A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008;122:1154-1160.
42.
Martorell A, De la Hoz B, Ibanez MD, Bone J, Terrados MS, Michavila A, et al: Oral desensitization as a useful treatment in 2-year-old children with cow's milk allergy. Clin Exp Allergy 2011;41:1297-1304.
43.
Pajno GB, Caminiti L, Ruggeri P, De Luca R, Vita D, La Rosa M, Passalacqua G: Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol 2010;105:376-381.
44.
Wood RA, Kim JS, Lindblad R, Nadeau K, Henning AK, Dawson P, Plaut M, Sampson HA: A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy. J Allergy Clin Immunol 2016;137:1103-1110. e11.
45.
Ebisawa M, Sato S, Utsunomiya T, Hayashi N, Imai T, Yanagida T: Rush oral immunotherapy for the treatment of hen's egg- and cow's milk-induced anaphylaxis; in Marone G, Triggiani M, Genovese A (eds): Translational Science: From Basic to Clinical Immunology and Allergy. Pisa, Pacini, 2012, pp 359-364.
46.
Upton J, Eiwegger T: How low should we go? Int Arch Allergy Immunol 2015;168:147-149.
47.
Hochwallner H: Ready for a milk shake? Int Arch Allergy Immunol 2014;164:167-168.
48.
Yanagida N, Sato S, Asaumi T, Okada Y, Ogura K, Ebisawa M: A single-center, case-control study of low-dose-induction oral immunotherapy with cow's milk. Int Arch Allergy Immunol 2015;168:131-137.
49.
Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al: Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011;128:3-20. e6.
50.
Straumann A, Simon HU: Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 2005;115:418-419.
51.
DeBrosse CW, Collins MH., Buckmeier Butz BK: Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. J Allergy Clin Immunol 2010;126:112-119.
52.
Sugnanam KKN, Collins JT, Smith PK, et al: Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis. Allergy 2007;62:1257-1260.
53.
Hofmann AM, Scurlock AM, Jones SM, et al: Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009;124:286-291.
54.
Ridolo E, De Angelis GL, Dall'Aglio P: Eosinophilic esophagitis after specific oral tolerance induction for egg protein. Ann Allergy Asthma Immunol 2011;106:73-74.
55.
Sánchez-García S, Rodríguez Del Río P, Escudero C, Martínez-Gómez MJ, Ibáñez MD: Possible eosinophilic esophagitis induced by milk oral immunotherapy. J Allergy Clin Immunol 2012;129:1155-1157.
56.
Fuentes-Aparicio V, Alvarez-Perea A, Infante S, Zapatero L, D'Oleo A, Alonso-Lebrero E: Specific oral tolerance induction in paediatric patients with persistent egg allergy. Allergol Immunopathol (Madr) 2013;41:143-150.
57.
Morais Silva P, Antunes J, Chambel M, Prates S, Leiria Pinto P: Diagnosis of eosinophilic esophagitis in an infant undergoing milk oral immunotherapy - a case report. Eur Ann Allergy Clin Immunol 2014;46:154-156.
58.
Semancik E, Sayej WN: Oral immunotherapy for peanut allergy induces eosinophilic esophagitis: three pediatric case reports. Pediatr Allergy Immunol 2016;27:539-541.
59.
Echeverría-Zudaire LÁ, Fernández-Fernández S, Rayo-Fernández A, Muñóz-Archidona C, Checa-Rodriguez R: Primary eosinophilic gastrointestinal disorders in children who have received food oral immunotherapy. Allergol Immunopathol (Madr) 2016;44:531-536.
60.
Mansfield LE, Wasserman R, Hutterman HR, Ruvalcaba M, Galluci A: Oral peanut immunotherapy (OPI) in the allergy office. Ann Allergy Asthma Immunol 2009;103(suppl 3):A13.
61.
Vickery BP, Scurlock AM, Steele P, et al: Early and persistent gastrointestinal side effects predict withdrawal from peanut oral immunotherapy (OIT). J Allergy Clin Immunol 2011;127(suppl 2):AB26.
62.
Wasserman RL, Sugerman RW, Nireku-Akaomeah N, Gallucci AR, Pence DM, Long NA: Peanut oral immunotherapy (OIT) of food allergy (FA) carries a significant risk of eosinophilic esophagitis (EoE). J Allergy Clin Immunol 2011;127(suppl 2):AB28.
63.
Antunes J, Chambel M, Prates S, Leiria-Pinto P: Cow's milk desensitization revealing hidden pathology. Allergy 2011;66(suppl 94):214.
64.
Stein ML, Levy MM, Goldberg MR, et al: Classification, prevalence and outcomes of non-IgE mediated reactions to oral food immunotherapy. J Allergy Clin Immunol 2012;129(suppl 2):AB29.
65.
Sugimoto M, Nagao M, Kondo M, Kainuma K, Fujisawa T: Food allergy and anaphylaxis - 2041. Rush oral immunotherapy for severe food allergy: one year follow up. World Allergy Organ J 2013;6(suppl 1):126.
66.
Ibrahim Aibo A, Terrados S, Villafana L, Perez R, Alavarez-Cuesta E, Camarero C: Eosinophilic esophagitis induced by milk oral immunotherapy in one patient. Allergy 2013;68(suppl 97):701.
67.
Nowak-Wegrzyn AH, Strong BD, Ananos D, Sampson HA: Long term follow up of children who incorporated extensively heated (baked milk) in the diet. J Allergy Clin Immunol 2013;133(suppl 2):AB107.
68.
Babaie D, Arshi S, Mesdaghi M, Chavoshzadeh Z, Bemanian MH, Tafakori M, Amirmoini M, Esmailzadeh H, Molatefi R, Rekabi M, Akbarpour N, Masoumi F, Fallahpour M: Cow's milk desensitization in anaphylactic patients: a new personalized-dose method. Iran J Allergy Immunol 2017;16:45-52.
69.
Lucendo AJ, Arias A, Tenias JM: Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2014;113:624-629.
70.
Hsieh FH: Oral food immunotherapy and iatrogenic eosinophilic esophagitis: an acceptable level of risk? Ann Allergy Asthma Immunol 2014;113:581-582.
71.
Wright BL, Kulis MD, Guo R, Orgel K, Wolf WA, Burks AW, et al: Food-specific IgG4 is associated with eosinophilic esophagitis. J Allergy Clin Immunol 2016;137:AB232.
72.
Savilahti EM, Kuitunen M, Savilahti E, Mäkelä MJ: Specific antibodies in oral immunotherapy for cow's milk allergy: kinetics and prediction of clinical outcome. Int Arch Allergy Immunol 2014;164:32-39.
73.
Muraki M, Gleich GJ, Kita H: Antigen-specific IgG and IgA, but not IgE, activate the effector functions of eosinophils in the presence of antigen. Int Arch Allergy Immunol 2011;154:119-127.
74.
Mulder DJ, Pooni A, Mak N, Hurlbut DJ, Basta S, Justinich CJ: Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis. Am J Pathol 2011;178:744-753.
75.
Rothenberg ME: Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004;113:11-29.
76.
Okamoto Y, Kurihara K: A case of eosinophilic esophagogastroenteritis which developed after rush oral immunotherapy for egg allergy. Jpn J Allergol 2015;64:57-62.
77.
Klein NC, Hargrove RL, Sleisenger MH, Jeffries GH: Eosinophilic gastroenteritis. Medicine (Baltimore) 1970;49:299-319.
78.
Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR: Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990;31:54-58.
79.
Choi JS, Lee KJ, Kim A, Yoo JK, Yang HR, Moon JS, Chang JY, Ko JS, Kang GH: Clinical manifestations and treatment outcomes of eosinophilic gastroenteritis in children. Pediatr Gastroenterol Hepatol Nutr 2015;18:253-260.
80.
Pineton de Chambrun G, Gonzalez F, Canva JY, Gonzalez S, Houssin L, Desreumaux P, Cortot A, Colombel JF: Natural history of eosinophilic gastroenteritis. Clin Gastroenterol Hepatol 2011;9:950-956. e1.
81.
Kinoshita Y, Furuta K, Shimaura N, Ishihara S, Sato S, Maruyama R, Ohara S, Matsumoto T, Sakamoto C, Matsui T, Ishikawa S, Chiba T: Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol 2013;48:333-339.
82.
Caldwell JM, Collins MH, Stucke EM, Putnam PE, Franciosi JP, Kushner JP, Abonia JP, Rothenberg ME: Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, Th2 immunity, and a unique gastric transcriptome. J Allergy Clin Immunol 2014;134:1114-1124.
83.
Prussin C, Lee J, Foster B: Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses. J Allergy Clin Immunol 2009;124:1326-1332 e6.
84.
Suzuki S, Homma T, Kurokawa M, Matsukura S, Adachi M, Wakabayashi K, Nozu F, Tazak T, Kimura T, Matsuura T, Fukuda M, Shiozawa E, Takimoto M: Eosinophilic gastroenteritis due to cow's milk allergy presenting with acute pancreatitis. Int Arch Allergy Immunol 2012;158(suppl 1):75-82.
85.
Tse KY, Christiansen SC: Eosinophilic gastroenteritis due to egg allergy presenting as acute pancreatitis. Allergy Rhinol (Providence) 2015;6:80-81.
86.
Yamada Y, Kato M, Isoda Y, Nishi A, Jinbo Y, Hayashi Y: Eosinophilic gastroenteritis treated with a multiple-food elimination diet. Allergol Int 2014;63(suppl 1):53-56.
87.
Lucendo AJ, Serrano-Montalban B, Arias A, Redondo O, Tenias JM: Efficacy of dietary treatment for inducing disease remission in eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr 2015;61:56-64.
88.
Pineton de Chambrun G, Desreumaux P, Cortot A: Eosinophilic enteritis. Dig Dis 2015;33:183-189.
89.
Chen MJ, Chu CH, Lin SC, Shih SC, Wang TE: Eosinophilic gastroenteritis: clinical experience with 15 patients. World J Gastroenterol 2003;9:2813-2816.
90.
Okpara N, Aswad B, Baffy G: Eosinophilic colitis. World J Gastroenterol 2009;15:2975-2979.
91.
Baek MS, Mok YM, Han WC, Kim YS: A patient with eosinophilic gastroenteritis presenting with acute pancreatitis and ascites. Gut Liver 2014;8:224-227.
92.
Sheikh R, Prindiville TP, Pecha RE, Ruebner BH: Unusual presentations of eosinophilic gastroenteritis: case series and review of literature. World J Gastroenterol 2009;15:2156-2161.
93.
Lyngbaek S, Adamsen S, Aru A, Bergenfeldt M: Recurrent acute pancreatitis due to eosinophilic gastroenteritis. Case report and literature review. JOP 2006;7:211-217.
94.
Maeshima A, Murakami H, Sadakata H, Saitoh T, Matsushima T, Tamura J, Karasawa M, Naruse T: Eosinophilic gastroenteritis presenting with acute pancreatitis. J Med 1997;28:265-272.
95.
Ogura K, Iikura K, Yanagida N, Sato S, Ebisawa M: Two patients with acute pancreatitis after undergoing oral food challenges. J Allergy Clin Immunol Pract 2016;4:984-986.
96.
Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S, Bousquet J, Calderon M, Compalati E, Durham SR, van Wijk RG, Larenas-Linnemann D, Nelson H, Passalacqua G, Pfaar O, Rosario N, Ryan D, Rosenwasser L, Schmid-Grendelmeier P, Senna G, Valovirta E, Van Bever H, Vichyanond P, Wahn U, Yusuf O: Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J 2014;7:6.
97.
Miehlke S, Alpan O, Schroder S, Straumann A: Induction of eosinophilic esophagitis by sublingual pollen immunotherapy. Case Rep Gastroenterol 2013;7:363-368.
98.
Bauer CS, Tvrdik MM, Schroeder S: Eosinophilic esophagitis induced by aeroallergen sublingual immunotherapy in an enteral feeding tube dependent pediatric patient. J Allergy Clin Immunol 2016;137:AB63.
99.
Patel C, Menon PK: A complication of eosinophilic esophagitis from sublingual immunotherapy. J Allergy Clin Immunol 2016;137:AB62.
100.
Béné J, Ley D, Roboubi R, Gottrand F, Gautier S: Eosinophilic esophagitis after desensitization to dust mites with sublingual immunotherapy. Ann Allergy Asthma Immunol 2016;116:583-584.
101.
Kim EH, Bird JA, Kulis M, Laubach S, Pons L, Shreffler W, Steele P, Kamilaris J, Vickery B, Burks AW: Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol 2011;127:640-646. e1.
102.
Fleischer DM, Burks AW, Vickery BP, Scurlock AM, Wood RA, Jones SM, Sicherer SH, Liu AH, Stablein D, Henning AK, Mayer L, Lindblad R, Plaut M, Sampson HA: Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 2013;131:119-127. e1-e7.
103.
Burks AW, Wood RA, Jones SM, Sicherer SH, Fleischer DM, Scurlock AM, et al: Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol 2015;135:1240-1248. e1-e3.
104.
Akuthota P, Weller PF: Spectrum of eosinophilic end-organ manifestations. Immunol Allergy Clin North Am 2015;35:403-411.
105.
Aceves SS, Ackerman SJ: Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am 2009;29:97-211.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.